Validation of a novel assay for cardiology drug screening using hESC-derived cardiomyocyte spheroids - “mini-hearts”

Nikolai Zhelev, Rachel Kaske, James L. Bown

    Research output: Contribution to journalMeeting Abstract

    Original languageEnglish
    Pages (from-to)S108
    Number of pages1
    JournalJournal of Biotechnology
    Volume231
    Issue numbersuppl
    Early online date20 Jul 2016
    DOIs
    Publication statusPublished - 10 Aug 2016
    EventEuropean Biotechnology Congress - Riga, Latvia
    Duration: 5 May 20167 May 2016

    Cite this

    @article{b14cde0184f348c28fd0da6447a3a0d2,
    title = "Validation of a novel assay for cardiology drug screening using hESC-derived cardiomyocyte spheroids - “mini-hearts”",
    author = "Nikolai Zhelev and Rachel Kaske and Bown, {James L.}",
    year = "2016",
    month = "8",
    day = "10",
    doi = "10.1016/j.jbiotec.2016.05.375",
    language = "English",
    volume = "231",
    pages = "S108",
    journal = "Journal of Biotechnology",
    issn = "0168-1656",
    publisher = "Elsevier Science B.V.",
    number = "suppl",

    }

    Validation of a novel assay for cardiology drug screening using hESC-derived cardiomyocyte spheroids - “mini-hearts”. / Zhelev, Nikolai; Kaske, Rachel; Bown, James L.

    In: Journal of Biotechnology, Vol. 231, No. suppl, 10.08.2016, p. S108.

    Research output: Contribution to journalMeeting Abstract

    TY - JOUR

    T1 - Validation of a novel assay for cardiology drug screening using hESC-derived cardiomyocyte spheroids - “mini-hearts”

    AU - Zhelev, Nikolai

    AU - Kaske, Rachel

    AU - Bown, James L.

    PY - 2016/8/10

    Y1 - 2016/8/10

    U2 - 10.1016/j.jbiotec.2016.05.375

    DO - 10.1016/j.jbiotec.2016.05.375

    M3 - Meeting Abstract

    VL - 231

    SP - S108

    JO - Journal of Biotechnology

    JF - Journal of Biotechnology

    SN - 0168-1656

    IS - suppl

    ER -